Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Mycovia Pharmaceuticals Inc an emerging biopharmaceutical company today announced that Jiangsu Hengrui Pharmaceuticals Co Ltd Hengrui Pharma held a recent conference in Shanghai China to recognize the listing of VIVJOA oteseconazole in the recent Nat...
With the growth and transformation of the mAb market particularly with the recent rapid rise of biosimilars a onesizefitsall approach to protein purification is no longer viable To address this Cytiva developed two new protein A resins the MabSelect...
Mabwell an innovative biopharmaceutical company with entire industry chain announced its novel BHtargeting ADC RD code MW has been approved by the NMPA to enter Phase IbII clinical trial in combination with a PD Inhibitor with or without antitumor th...
TCI Biotech a CDMO organization specializing in health and wellness products is spotlighting its comprehensive USbased glass bottling solution for liquid supplements positioning it as a cornerstone of its expanded CDMO services Designed for nutraceut...
ShinEtsu Chemical Co Ltdwill make investments at two of its bases the subsidiary SE Tylose GmbH Co KG Wiesbaden Germany and the Naoetsu Plant in Joetsu Niigata Prefecture to strengthen its pharmaceutical cellulose business
Shionogi Co Ltd is pleased to announce that it has entered into an exclusive licensing agreement with Link Medical Products Pty Ltd hereinafter Link part of Clinigen the global specialty pharmaceutical services group
Pfizer Inc announced today that the European Commission EC has issued a decision amending the marketing authorization for ABRYSVO the companys bivalent respiratory syncytial virus RSV prefusion F RSVpreF vaccine
Amneal Pharmaceuticals Inc a global biopharmaceutical company and Shilpa Medicare Limited Shilpa today announced the US launch of BORUZU a new presentation of bortezomib for readytouse subcutaneous administration or intravenous
Analytica Vietnam Vietnams premier international trade fair for laboratory technology analysis biotechnology and diagnostics will officially open tomorrow at the Saigon Exhibition and Convention Center SECC
The first patient has been dosed in the DESTINYGastric phase trial evaluating ENHERTU trastuzumab deruxtecan in combination with a fluoropyrimidine chemotherapy FU or capecitabine and Mercks known as MSD
